Research at NCCS is supported by the NCC Research Fund. The fund supports innovative research to find the breakthroughs that will change how we understand, diagnose, treat and ultimately cure cancer.
Our team of over 240 researchers are working on 66 wide ranging research priorities, which include better screening methods, improving treatments, nursing research and cancer prevention.
Our research is special because it concentrates on Asian-specific cancers, those that are affecting us here in Singapore. This is important research that is not being done elsewhere in the World, it will help save the lives of our friends, families and colleagues.
This is only possible with the help of people like you. Thank you for your continued support. It is your kind donations that enable us to help more people with cancer, and save more lives.
Our research programmes include projects such as the promising field of Immunotherapy, Genetics and Geriatric cancer research.
Immunotherapy works by using the body’s immune system to fight cancer. We aim to raise $9 million to fund the Centre for Cancer Immunotherapy which will spearhead this exciting new area of research.
Donate here to support this work.
Dr Toh Han Chong, who leads our Immunotherapy laboratory, said “We were the first in Singapore and the region to conduct clinical trials of cancer vaccines and T cell therapy when immunotherapy had yet to come in to the mainstream.”
Dr Toh believes that Immunotherapy has the potential to treat many diseases besides cancer, with the National Cancer Centre Singapore as the leader of this emerging field in Asia.
It is estimated that up to 30% of cancers could have genetics as a contributing factor. The Centre for
Cancer Genomic Medicine aims to understand the genetic basis for familial and rare cancers in Singapore and the region. To fund this vital work we need to raise $4.5 million.
Donate here to support the Centre.
The Cancer Genetics Service team, led by Dr Joanne Ngeow, runs research in the lab to find novel genes that are unique to Chinese, Malay or Indian populations which might account for their risk of cancer.
The team’s research helps identify genes that may increase cancer risk, as well as developing new drugs, therapies and treatments tailored to specific
Another of the many programmes that the NCC Research Fund supports is the
Geriatric Oncology Research Programme. Cancer is more common in older people, with 60% of cancers occurring in people aged 60 years and above. Our research looks at how best to treat and care for older cancer patients. Support this vital work by
Dr Ravindran Kanesvaran, has developed an assessment tool which includes an evaluation of a patient’s diet, exercise routine and their understanding of their diagnosis. It also takes in to account any other conditions they may have, such as diabetes or Alzheimer’s, and how these may interact with cancer treatment. These assessments help determine the best treatment and care for older patients.
Philanthropic gifts ensure that future generations will continue to benefit from even better medical care and improved quality of life. Philanthropic gifts ensure that future generations will continue to be Philanthropic gifts ensure that future generations will continue to be
- Jose Baselga, Physician-in-Chief and Chief Medical Officer
Subscribe to our mailing list to get the updates to your email inbox...
11 Hospital Crescent, Singapore 169610 +65 6436 8000